Company news

PRF Technologies Ltd. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

PainReform Advances Pain Relief Solution, PRF-110, in Phase 3 Trial to Combat Opioid Crisis

May 6, 2024

PainReform Announces Closing of $4 Million Public Offering

April 17, 2024

PainReform Announces Pricing of $4 Million Public Offering

April 15, 2024

PainReform Reports Successful Head-to-Head Comparison of PRF-110 Versus Market Leading Post Surgical Analgesia for Extended Postoperative Pain Relief

January 2, 2024

PainReform Announces Exercise of Warrants for Approximately $1.3 Million in Gross Proceeds

December 25, 2023

PainReform Provides Business Update for the Third Quarter of 2023

November 14, 2023

PainReform Announces Plans to Commence Second Part of Phase 3 Clinical Trial to Evaluate PRF-110 in Patients Undergoing Bunionectomy Surgery Following Positive FDA Review of Drug Master File

September 10, 2023

PainReform Provides Business Update for the Second Quarter of 2023

August 9, 2023

PainReform Regains Compliance with Nasdaq Continued Listing Requirements

July 18, 2023

PainReform Announces Pricing of $1.5 Million Concurrent Registered Direct Offering and Private Placement

July 13, 2023

PainReform Announces Pricing of $2.7 Million Concurrent Registered Direct Offering and Private Placement

July 11, 2023

PainReform Announces Positive Pharmacokinetic (PK) Data in First Part of Phase 3 Clinical Trial of PRF-110 in Patients Undergoing Bunionectomy Surgery

May 17, 2023

PainReform Provides Business Update for the First Quarter of 2023

May 14, 2023

PainReform Announces Positive Safety Data in First Part of Phase 3 Clinical Trial of PRF-110 in Patients Undergoing Bunionectomy Surgery

April 30, 2023

PainReform Completes First Part of Phase 3 Clinical Trial in Patients Undergoing Bunionectomy Surgery

March 27, 2023

PainReform Provides Year-End Business Update; Commences Phase 3 Clinical Trial of PRF-110 in Bunionectomy

March 15, 2023

PainReform Announces Commencement of Phase 3 Clinical Trial to Evaluate PRF-110 in Patients Undergoing Bunionectomy Surgery

March 13, 2023

PainReform Ltd. (NASDAQ: PRFX) Announces Receipt of Extension to Meet the Nasdaq’s Minimum Bid Price Requirement

February 6, 2023

PainReform Provides Further Update on Manufacturing of PRF-110

November 7, 2022

PainReform Provides PRF-110 Manufacturing Update

October 3, 2022

PainReform Provides Business Update for the Second Quarter of 2022

August 15, 2022

PainReform Provides Business Update for the First Quarter of 2022

May 16, 2022

PainReform Provides Year-End Business Update; on Track to Commence Phase 3 Trial of PRF-110 for Non-Opiate Post-Operative Pain Relief in the Second Half of 2022

March 16, 2022

PainReform Provides Business Update for the Third Quarter of 2021

November 15, 2021

PainReform Provides Business Update for the Second Quarter of 2021

August 15, 2021

PainReform Provides Business Update for the First Quarter of 2021

May 12, 2021

PainReform Provides Year-End Business Update and Reports Progress Towards Commencing Phase 3 Trial of PRF-110 for Non-Opiate Post-Operative Pain Relief

March 17, 2021

PainReform Announces $6.0 Million Private Placement

March 7, 2021

PainReform Appoints Rita Keynan as Vice President of Pharmaceutical Operations

January 5, 2021

PainReform Announces Appointment of Lotus Clinical Research as CRO for Phase 3 Clinical Trial of PRF-110

January 3, 2021

PainReform Appoints Senior Pharmaceutical Executive and Finance Veteran Ilan Hadar as Chief Executive Officer

November 22, 2020

PainReform Welcomes Successful Healthcare and Capital Markets Executive Dr. Ellen Baron to Board of Directors

November 11, 2020

PainReform Welcomes Senior Pharmaceutical Executive and Venture Capitalist Augustine Lawlor to Board of Directors

November 4, 2020

PainReform Commences Preparations for Pivotal Phase 3 Clinical Trials

September 28, 2020

PainReform Announces Closing of $20.0 Million Initial Public Offering

September 8, 2020

← Newer news releases

Decks

The 5 newest of 7 decks. Every deck is listed under its year.